France Archives

News and Trends 13 Mar 2018

French Biotech Takes its Oral Diabetes Drug to Phase III

Update (13/03/2018): Poxel has started two more Phase III trials in Japan testing its drug for type 2 diabetes, imeglimin. This oral drug has shown potential to lower glucose levels thanks to a mechanism of action that targets the pancreas, the liver and muscles simultaneously. The new trials will confirm whether these effects are maintained in a larger […]

March 13, 2018 - 3 minutesmins - By Melanie De Almeida

evotec sanofi infectious disease pipeline

More News! 8 Mar 2018

Evotec Takes Over Sanofi’s Infectious Disease Pipeline

Evotec will be getting over 10 assets, €60M upfront and about 100 scientists from Sanofi’s infectious disease research unit to work on developing new antimicrobials. Evotec has entered exclusive negotiations with Sanofi to accelerate infectious disease R&D through a new innovation platform located near Lyon, France, that will be open to academia, private companies, foundations and government agencies. Sanofi, […]

March 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Mar 2018

French Biotech Targets Gut Microbiome to Treat Diabetes

Valbiotis has shown that its treatment restores diversity in a population of gut microorganisms imbalanced by type 2 diabetes in mice. Valbiotis, based in Périgny, France, wants to treat type 2 diabetes by restoring the balance of microbial populations in the gut microbiome. New data from a metagenomic sequencing study in mice has shown that its drug, […]

March 8, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 1 Mar 2018

Could This Parisian Biotech Startup’s Cancer Treatment Compete With Merck and Novartis?

Stimunity, a Parisian biotech, secured a 2M€ seed investment to develop a cancer treatment that could compete with that of big players such as Merck and Novartis. Stimunity is a preclinical-stage startup company which develops drugs targeting a new cell signalling pathway to treat cancer. The company secured funding from Portage, a US-Canadian firm that […]

March 1, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 27 Feb 2018

Update: Deinove is About to Launch a Bacterial Anti-Aging Skincare Product

Update (27/2/2018): Deinove produced the first industrial batch of its carotenoid product and plans to launch the cosmetic skincare treatment at the In-Cosmetics tradeshow in Amsterdam this coming April. The news resulted in a soaring 57% increase of Deinove’s stock price. Originally published on 19/12/2017 Deinove has set the wheels in motion as it looks […]

February 27, 2018 - 2 minutesmins - By Alex Dale

News and Trends 27 Feb 2018

DBV Technologies’ Milk Allergy Patch Helps Kids in a Phase II Trial

DBV Technologies’ candidate could be the first treatment for allergies to cow milk after its Viaskin Milk skin patch achieved positive Phase II results. DBV Technologies is developing a skin patch, Viaskin, as an immunotherapy for the treatment peanut, egg, and milk allergies. In a Phase II study, Viaskin Milk has desensitized children between the […]

February 27, 2018 - 3 minutesmins - By Alex Dale

News and Trends 21 Feb 2018

Implantation of Carmat’s Artificial Heart Begins in Denmark to Beat Low Enrolment

Carmat’s artificial heart is being tested in patients with heart failure. A hospital in Copenhagen will implant the device, which the biotech hopes will boost patient enrolment to its PIVOTAL trial. Carmat has developed the world’s most advanced fully artificial heart, which has been designed for patients suffering from end-stage biventricular heart failure. The biotech has […]

February 21, 2018 - 3 minutesmins - By Alex Dale

News and Trends 20 Feb 2018

This Gene Therapy for Vision Loss is Safe and Effective After Two Years

The results of a long-term follow-up suggest that GenSight’s gene therapy for Leber hereditary optic neuropathy can provide safe and effective treatment for the genetic cause of vision loss. GenSight develops gene therapies to preserve or restore vision in patients with neurodegenerative diseases of the retina. The biotech’s lead candidate is GS010, which is currently […]

February 20, 2018 - 3 minutesmins - By Alex Dale

Interview 19 Feb 2018

Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune Disease

CAR-T cells are all the rage as the latest treatment for cancer. But what if we could apply this same technology to treat autoimmune disease? Curious to learn whether this new technology could revolutionize yet another field of medicine, I talked to Stephane Boissel, CEO of TxCell, to discuss the future of the field and his […]

February 19, 2018 - 9 minutesmins - By Clara Rodríguez Fernández

News and Trends 16 Feb 2018

French Biotech Gets a CRISPR Patent for CAR-T Research

Update (16/02/2018): On top of the European patent it got last July, Cellectis now also has two US patents to use CRISPR technology to make CAR-T cells. Cellectis has said it will offer licenses to companies that want to use CRISPR gene editing in T cells. Not just for inserting CAR antigens, but also other editions […]

February 16, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Cellnovo insulin pump diabetes management

News and Trends 15 Feb 2018

This Mobile Diabetes Management System Can Reduce Hypoglycemia by 39%

The wireless system for diabetes management developed by Cellnovo can significantly reduce life-threatening events of hypoglycemia in patients with type 1 diabetes. A clinical study that followed type 1 diabetes patients for a year has concluded that a new mobile system for diabetes management could reduce events of hypoglycemia by 29% in adults — from […]

February 15, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Feb 2018

Startup Studio Raises €90M to Create and Develop Exciting Young Biotechs

iBionext has closed its Growth Fund, which has raised money from investors like Bpifrance to help young biotechs to reach their potential. iBionext is a French ‘startup studio’ that specializes in the creation and development of startups in the healthcare industry. It has closed its iBionext Growth Fund at €90M, which will be used to finance […]

February 15, 2018 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

French Biotech Takes its Oral Diabetes Drug to Phase III

Evotec Takes Over Sanofi’s Infectious Disease Pipeline

French Biotech Targets Gut Microbiome to Treat Diabetes

Could This Parisian Biotech Startup’s Cancer Treatment Compete With Merck and Novartis?

Update: Deinove is About to Launch a Bacterial Anti-Aging Skincare Product

DBV Technologies’ Milk Allergy Patch Helps Kids in a Phase II Trial

Implantation of Carmat’s Artificial Heart Begins in Denmark to Beat Low Enrolment

This Gene Therapy for Vision Loss is Safe and Effective After Two Years

Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune Disease

French Biotech Gets a CRISPR Patent for CAR-T Research

This Mobile Diabetes Management System Can Reduce Hypoglycemia by 39%

Startup Studio Raises €90M to Create and Develop Exciting Young Biotechs

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!